• 

  Christiana Egi: Breaking Down Dementia’s Stigmas for the Young and Old
• 

  What Can Dolphins Teach Us About Alzheimer’s?
• 

  Leqembi Clinical Trials Aren’t Over—Half of Participants Will Get the Drug for Free
• 

  Cancer Appears to Reduce Dementia Risk – Here’s Why
• 

  How ‘Exercise Snacks’ Could Feed the Brain and Prevent Dementia
• 

  Can COVID-19 Cause Alzheimer’s or Dementia?
• 

  Lecanemab Approved: New Disease-Modifying Alzheimer’s Drug Leqembi on the Market
• 

  On the Brink of a Lecanemab FDA Decision, What Do We Know About the Drug’s Safety?
• 

  Beyond the Hype: What Does the Lecanemab News Mean for People with Alzheimer’s?
• 

  Cuba Has an Experimental Alzheimer’s Drug In Human Trials
• 

  A New Kind of Alzheimer’s Drug, AD101, Makes Its Way
• 

  Meet Eli Lilly’s New Phase 3 Alzheimer’s Drug, Remternetug
• 

  Why Some Researchers Are Calling Alzheimer’s “Type 3 Diabetes”
• 

  First-Ever Drug for Alzheimer’s Agitation, Brexpiprazole, Nears Finish Line
• 

  CTAD: Lecanemab On Track to File for FDA Approval In Early 2023

Previous222324Next